Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Blood

• Publication date

  2015-05-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2014-12-613703PMID 25805812PMCID PMC4463809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation

  2014cited by this paper
• Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q

  2013influential reference
• Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2

  2013cited by this paper
• Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX

  2013cited by this paper
• CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia

  2013influential reference
• Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.

  2012cited by this paper
• Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value

  2012cited by this paper
• Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.

  2012cited by this paper
• Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains.

  2012cited by this paper
• High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia.

  2012influential reference
• Growth Inhibition of a Myeloid Leukemia Cell Line with 5q Deletion by Beta-Catenin Inhibition

  2012cited by this paper
• GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.

  2012cited by this paper
• Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.

  2012cited by this paper
• Therapeutic advances in acute myeloid leukemia.

  2011cited by this paper
• Haploinsufficiency of Dnmt1 Impairs Leukemia Stem Cell Function Through Derepression of Bivalent Chromatin Domains

  2011cited by this paper
• MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia.

  2011cited by this paper
• DNMT3A mutations in acute myeloid leukemia

  2011cited by this paper
• RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer.

  2011cited by this paper
• Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia

  2011cited by this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cited by this paper
• Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.

  2010cited by this paper
• A Novel Wilms Tumor 1 (WT1) Target Gene Negatively Regulates the WNT Signaling Pathway*

  2010influential reference
• The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML

  2010cited by this paper
• The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia

  2009cited by this paper
• Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.

  2009cited by this paper
• Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.

  2009cited by this paper
• AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

  2009cited by this paper
• Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases

  2009cited by this paper
• Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling

  2009cited by this paper
• Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia

  2009cited by this paper
• Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

  2009cited by this paper
• CXXC5 Is a Novel BMP4-regulated Modulator of Wnt Signaling in Neural Stem Cells*

  2009cited by this paper
• Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis.

  2009cited by this paper
• The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial

  2009cited by this paper
• The CXXC finger 5 protein is required for DNA damage-induced p53 activation

  2009influential reference
• Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells

  2009cited by this paper
• MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.

  2008cited by this paper
• Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins

  2007cited by this paper
• Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.

  2006cited by this paper
• Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis

  2006cited by this paper
• High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.

  2006cited by this paper
• Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemia

  2005cited by this paper
• The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.

  2005cited by this paper
• Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.

  2005cited by this paper
• Prognostically useful gene-expression profiles in acute myeloid leukemia.

  2004cited by this paper
• Novel loss‐of‐function mutations of the haematopoiesis‐related transcription factor, acute myeloid leukaemia 1/runt‐related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome

  2004cited by this paper
• Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells

  2004cited by this paper
• TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)

  2003cited by this paper
• Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

  2003cited by this paper
• Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

  2003cited by this paper
• Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

  2001cited by this paper
• Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia.

  2001cited by this paper
• Brief Report Results and Discussion

  year unknowncited by this paper

• CXXC5 is a ubiquitinated protein and is degraded by the ubiquitin‐proteasome pathway

  2025cites this paper
• Signal integrator function of CXXC5 in Cancer

  2025cites this paper
• CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1.

  2024cites this paper
• MiR-28-3p regulates high glucose-induced endothelial dysfunction by targeting CXXC5

  2023cites this paper
• Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway

  2022cites this paper
• Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation

  2021cites this paper
• Methyltransferase DNMT3B in leukemia

  2020cites this paper
• The epigenetic regulator RINF (CXXC5) maintains SMAD7 expression in human immature erythroid cells and sustains red blood cell expansion

  2020influential citation
• Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients’ prognosis

  2020cites this paper
• The multiple ways Wnt signaling contributes to acute leukemia pathogenesis

  2020cites this paper
• Frontline Science: Cxxc5 expression alters cell cycle and myeloid differentiation of mouse hematopoietic stem and progenitor cells

  2020cites this paper
• Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse

  2019cites this paper
• Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells

  2019influential citation
• CXXC5 Mediates P. gingivalis-suppressed Cementoblast Functions Partially via MAPK Signaling Network

  2019cites this paper
• Wnt Signalling in Acute Myeloid Leukaemia

  2019cites this paper
• Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype

  2019cites this paper
• CXXC5: A novel regulator and coordinator of TGF‐β, BMP and Wnt signaling

  2018cites this paper
• CXXC5 suppresses hepatocellular carcinoma by promoting TGF-&bgr;-induced cell cycle arrest and apoptosis

  2018cites this paper
• Downregulation of ROS 1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines

  2018cites this paper
• Feedback regulation of TGF-β signaling.

  2018cites this paper
• Downregulation of ROS1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines.

  2018cites this paper
• Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer

  2018cites this paper
• Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates

  2018cites this paper
• Alterations in WNT Signaling in Leukemias

  2018cites this paper
• Existing and Emerging Molecular Technologies in Myeloid Neoplasms

  2018cites this paper
• Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms

  2017cites this paper
• Cancer subtype identification using somatic mutation data

  2017cites this paper
• DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome

  2017cites this paper
• Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report

  2017cites this paper
• Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism

  2017cites this paper
• The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt/β‑catenin pathway and DNA methyltransferase-1.

  2017cites this paper
• Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia

  2017cites this paper
• Tracking sub-clonal mutation frequencies throughout lymphoma development identifies cancer drivers in mouse models of lymphoma

  2017cites this paper
• Tracking Subclonal Mutation Frequencies Throughout Lymphomagenesis Identifies Cancer Drivers in Mouse Models of Lymphoma

  2017cites this paper
• Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia

  2016cites this paper
• Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients

  2016cites this paper
• Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia

  2016cites this paper
• Assessment of Minimal Residual Disease in Standard-Risk AML.

  2016cites this paper
• Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia

  2016cites this paper
• Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?

  2016cites this paper
• Retroviral insertional mutagenesis identifies the del(5q) genes, CXXC5, TIFAB and ETF1, as well as the Wnt pathway, as potential targets in del(5q) myeloid neoplasms

  2016cites this paper
• Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia

  2016cites this paper
• Unraveling the (epi)genetic makeup of myeloid malignancies

  2016cites this paper
• Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.

  2016cites this paper
• Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.

  2016cites this paper
• High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia

  2016cites this paper
• High Expression of CPT 1 A Predicts Adverse Outcomes : A Potential Therapeutic Target for Acute Myeloid Leukemia

  2016influential citation
• DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.

  2016cites this paper
• EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway

  2016cites this paper
• Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia

  2015cites this paper
• Haploinsufficient loss of multiple 5q genes may fine-tune Wnt signaling in del(5q) therapy-related myeloid neoplasms.

  2015cites this paper
• 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.

  2015cites this paper
• Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation

  2014cites this paper